Search

Your search keyword '"Chiveri, L"' showing total 47 results

Search Constraints

Start Over You searched for: Author "Chiveri, L" Remove constraint Author: "Chiveri, L"
47 results on '"Chiveri, L"'

Search Results

1. Author Correction: Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology (Nature Genetics, (2021), 53, 12, (1636-1648), 10.1038/s41588-021-00973-1)

2. Usability Testing of a New Digital Integrated Health Ecosystem (PainRELife) for the Clinical Management of Chronic Pain in Patients with Early Breast Cancer: Protocol for a Pilot Study

3. Detection of disability worsening in relapsing-remitting multiple sclerosis patients: a real-world roving Expanded Disability Status Scale reference analysis from the Italian Multiple Sclerosis Register

4. Effect modification of the association between total cigarette smoking and ALS risk by intensity, duration and time-since-quitting: Euro-MOTOR

5. Risk of multiple sclerosis relapses when switching from fingolimod to cell-depleting agents: the role of washout duration

6. Author Correction: Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology

7. Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology (vol 53, pg 1636, 2021)

8. Author Correction: Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology (Nature Genetics, (2021), 53, 12, (1636-1648), 10.1038/s41588-021-00973-1)

9. The Italian multiple sclerosis register

10. Effect modification of the association between total cigarette smoking and ALS risk by intensity, duration and time-since-quitting: Euro-MOTOR

11. Disease modifying therapies and Covid‐19 severity in Multiple Sclerosis

12. Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology

13. Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology

14. Disease-Modifying Therapies and Coronavirus Disease 2019 Severity in Multiple Sclerosis

16. Multicentre, cross-cultural, population-based, case-control study of physical activity as risk factor for amyotrophic lateral sclerosis

17. Detection of disability worsening in relapsing-remitting multiple sclerosis patients: a real-world roving Expanded Disability Status Scale reference analysis from the Italian Multiple Sclerosis Register

18. Association between alcohol exposure and the risk of amyotrophic lateral sclerosis in the Euro-MOTOR study

22. Is firstly diagnosed ALS really ALS? Results of a population-based study with long-term follow-up

23. A case-control study of hormonal exposures as etiologic factors for ALS in women

24. Physical activity and amyotrophic lateral sclerosis: A European population-based case-control study

25. Long-term survival in amyotrophic lateral sclerosis: A population-based study

26. Physical activity and amyotrophic lateral sclerosis: A European population-based case-control study

27. Extrapyramidal and cognitive signs in amyotrophic lateral sclerosis: A population based cross-sectional study

28. Efficacy and safety of glatiramer acetate in multiple sclerosis patients with allergic respiratory diseases

29. Retrospective study of patients affected of a large population with mitochondrial disorders: clinical, morphological and molecular genetic evaluation

30. Retrospective study of a large population of patients with asymptomatic or minimally symptomatic raised serum creatine kinase levels

31. Lack of apoptosis in mitochondrial encephalomyopathies

34. Disease-Modifying Therapies and Coronavirus Disease 2019 Severity in Multiple Sclerosis

35. Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology

36. Mutation analysis of the lamin A/C gene (LMNA) among patients with different cardiomuscular phenotypes

37. An overview on disease modifying and symptomatic drug treatments for multiple sclerosis.

38. Development and validation of an electronic Symbol-Digit Modalities Test for remote monitoring of people with multiple sclerosis.

39. Support for Chronic Pain Management for Breast Cancer Survivors Through Novel Digital Health Ecosystems: Pilot Usability Study of the PainRELife Mobile App.

40. Usability Testing of a New Digital Integrated Health Ecosystem (PainRELife) for the Clinical Management of Chronic Pain in Patients With Early Breast Cancer: Protocol for a Pilot Study.

41. Limbic encephalitis in a COVID-19 patient?

42. Impact of natural menopause on multiple sclerosis: a multicentre study.

43. Extrapyramidal and cognitive signs in amyotrophic lateral sclerosis: A population based cross-sectional study.

44. Schizophreniform disorder with cerebrospinal fluid PCR positivity for herpes simplex virus type 1.

45. Lack of apoptosis in patients with progressive external ophthalmoplegia and mutated adenine nucleotide translocator-1 gene.

46. Retrospective study of a large population of patients with asymptomatic or minimally symptomatic raised serum creatine kinase levels.

47. Retrospective study of a large population of patients affected with mitochondrial disorders: clinical, morphological and molecular genetic evaluation.

Catalog

Books, media, physical & digital resources